Cargando…

Matrix Metalloproteinase-9 as Prognostic Factor for the Treatment of HER-2 Enriched Breast Cancer

BACKGROUND: MMP-9 plays a significant role in invasion and migration of tumor cells and metastasis. A combination MMP-9 biomarker with HER2 and Ki-67 is expected to provide more specificity in prognosis for better breast cancer (BC) treatment options. METHODS: A retrospective cohort of 34 patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khambri, Daan, Suyuthie, Heldrian Dwinanda, Hilbertina, Noza, Yetti, Husna, Purwanto, Denni Joko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360959/ https://www.ncbi.nlm.nih.gov/pubmed/35345375 http://dx.doi.org/10.31557/APJCP.2022.23.3.1013

Ejemplares similares

Differences in Brain-Derived Neurotrophic Factor and Matrix Metalloproteinase-9 between Appropriate Neonates between Normal Birth Weight and Intrauterine Growth Restriction
por: Ardiani, Yessi, et al.
Publicado: (2019)

Volumetric Absorptive Microsampling as a Sampling Alternative in Clinical Trials and Therapeutic Drug Monitoring During the COVID-19 Pandemic: A Review
por: Harahap, Yahdiana, et al.
Publicado: (2020)

Analysis of the Doxorubicin and Doxorubicinol in the Plasma of Breast Cancer Patients for Monitoring the Toxicity of Doxorubicin
por: Harahap, Yahdiana, et al.
Publicado: (2020)

The correlation between the level of 3-hydroxypropyl mercapturic acid, CYP2B6 polymorphisms, and hematuria occurrences after cyclophosphamide administration and its bioanalytical methods: A systematic review
por: Harahap, Yahdiana, et al.
Publicado: (2021)

Phenotyping Study of Cyclophosphamide 4-Hydroxylation in Malay Cancer Patients
por: Hasanah, Yesi Ihdina Fityatal, et al.
Publicado: (2021)

Determination of O(6)-Methylguanine in dried blood spot of breast cancer patients after cyclophosphamide administration()
por: Harahap, Yahdiana, et al.
Publicado: (2021)

Prognostic role of matrix metalloproteinase 9 in early breast cancer
por: Kalavska, Katarina, et al.
Publicado: (2021)

Outcomes of Trastuzumab Therapy for 6 and 12 Months in Indonesian National Health Insurance System Clients with Operable HER2-Positive Breast Cancer
por: Harahap, Wirsma Arif, et al.
Publicado: (2017)

Plasma Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 as Prognostic Biomarkers in Critically Ill Patients
por: Duda, Izabela, et al.
Publicado: (2020)

Pan-cancer analysis of the prognostic and immunological role of matrix metalloproteinase 9
por: Zhang, Jie, et al.
Publicado: (2023)

The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer
por: Zarkesh, Maryam, et al.
Publicado: (2018)

Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003)

Interleukin-33, matrix metalloproteinase-9, and tissue ınhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Important role of matrix metalloproteinase 9 in epileptogenesis
por: Wilczynski, Grzegorz M., et al.
Publicado: (2008)

Expression of Matrix Metalloproteinase-9 in Gastric Cancer
por: R, Prathipaa, et al.
Publicado: (2021)

Correlation between expression of matrix metalloproteinase-2 (MMP-2), and matrix metalloproteinase-9 (MMP-9) and angiogenesis in colorectal adenocarcinoma.
por: Kim, T. S., et al.
Publicado: (1999)

Erratum: Interleukin-33, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinase-1 in myocardial infarction
por: Guzel, Savas, et al.
Publicado: (2013)

Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation
por: Wei, Ting, et al.
Publicado: (2016)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Association of Fascin and matrix metalloproteinase-9 expression with poor prognostic parameters in breast carcinoma of Egyptian women
por: Youssef, Nermeen Salah, et al.
Publicado: (2014)

The prognostic values of matrix metalloproteinases in ovarian cancer
por: Zeng, Linchai, et al.
Publicado: (2019)

Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study
por: Wang, Miaomiao, et al.
Publicado: (2014)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
por: Kudelski, Jacek, et al.
Publicado: (2023)

Expression and Significance of Matrix Metalloproteinase-2 and Matrix Metalloproteinas-9 in Endometriosis
por: Barbe, Adrian Mykhailovych, et al.
Publicado: (2020)

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
por: Manso, Helena, et al.
Publicado: (2010)

Expression and Concentration of Matrix Metalloproteinase 9 and Tissue Inhibitor of Matrix Metalloproteinases 1 in Laryngeal Squamous Cell Carcinoma
por: Matulka, Marlena, et al.
Publicado: (2019)

Correlation of matrix metalloproteinase 3 and matrix metalloproteinase 9 levels with non-motor symptoms in patients with Parkinson’s disease
por: Liu, Chuan Ze, et al.
Publicado: (2022)

Expression and prognostic relevance of Cyclophilin A and matrix metalloproteinase 9 in esophageal squamous cell carcinoma
por: Li, Yi, et al.
Publicado: (2013)

Prognostic effect of matrix metalloproteinase-9 in patients with resected Non small cell lung cancer
por: Lee, Chang Young, et al.
Publicado: (2015)

Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies
por: Zhou, Jian, et al.
Publicado: (2018)

A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities
por: ZHANG, HONGQI, et al.
Publicado: (2014)

Elevated matrix metalloproteinase-9 in patients with systemic sclerosis
por: Kim, Wan-Uk, et al.
Publicado: (2005)

Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis
por: Wang, Ling-Feng, et al.
Publicado: (2010)

Matrix-metalloproteinase-9 is cleaved and activated by Cathepsin K
por: Christensen, Jon, et al.
Publicado: (2015)

The Role of Matrix Metalloproteinase-9 in Atherosclerotic Plaque Instability
por: Li, Tiewei, et al.
Publicado: (2020)

Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression
por: Li, Hongmin, et al.
Publicado: (2022)

Injection of Matrix Metalloproteinase-9 Leads to Ventricular Remodeling
por: Zhu, Enzheng, et al.
Publicado: (2022)

Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9
por: Takai, Shinji, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f054eg2gohqnorsovv56td4ubb